000 | 01430 a2200493 4500 | ||
---|---|---|---|
005 | 20250513162137.0 | ||
264 | 0 | _c19990204 | |
008 | 199902s 0 0 eng d | ||
022 | _a0028-3878 | ||
024 | 7 |
_a10.1212/wnl.52.1.176 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAngelini, C | |
245 | 0 | 0 |
_aThe clinical spectrum of sarcoglycanopathies. _h[electronic resource] |
260 |
_bNeurology _cJan 1999 |
||
300 |
_a176-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aCytoskeletal Proteins _xgenetics |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aDystroglycans |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenetic Testing |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMembrane Glycoproteins _xgenetics |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMovement |
650 | 0 | 4 |
_aMuscular Dystrophies _xgenetics |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aNeurologic Examination |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aSarcoglycans |
650 | 0 | 4 | _aSeverity of Illness Index |
700 | 1 | _aFanin, M | |
700 | 1 | _aFreda, M P | |
700 | 1 | _aDuggan, D J | |
700 | 1 | _aSiciliano, G | |
700 | 1 | _aHoffman, E P | |
773 | 0 |
_tNeurology _gvol. 52 _gno. 1 _gp. 176-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.52.1.176 _zAvailable from publisher's website |
999 |
_c9883545 _d9883545 |